Viewing Study NCT04289103


Ignite Creation Date: 2025-12-24 @ 7:49 PM
Ignite Modification Date: 2025-12-28 @ 7:27 PM
Study NCT ID: NCT04289103
Status: UNKNOWN
Last Update Posted: 2020-12-17
First Post: 2020-02-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of EFficacy and SaFEty of Leukotac (Inolimomab) in Pediatric Patients With SR-aGvHD
Sponsor: ElsaLys Biotech
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module